Inaticabtagene autoleucel is under clinical development by Juventas Cell Therapy and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia. According to GlobalData, Phase I drugs for ...

Some types of sickle cell disease cause severe illness, while others have a mild or unapparent course. Sickle cell disease is present from birth and inherited from genes you receive from your parents.

Editas on Thursday kicked off a cost-cutting transition initiative after its hunt for a development sponsor for its sickle cell disease therapy renizgamglogene ... affect several members of the ...

Here are a few of the benefits of outsourcing your hospital’s anesthesia revenue cycle management: Electronic Health Records (EHRs): Great for charting not for anesthesia billing Most hospitals and ...

Editas Medicine said Thursday afternoon it will lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell disease and shifts focus.

Funmi Dasaolu receives funding from The National Institute for Health and Care Research. Stephen Hibbs receives funding from the Wellcome Trust. In December 2023, 34-year-old Dave Onawelo told ...

Tim Walz and our state Legislature for their leadership in creating a pathway to give Minnesotans access to transformative therapies for sickle cell disease. People struggling with chronic ...

Renowned content creator Bon Sevic has passed away after a lifelong battle with sickle cell disease The Kibra-based digital ... current affairs, Social media management, audience engagement and ...

The dual Wiz and ZBTB7A degrader entered into a first Phase 1/2 sickle cell disease trial in July, 1 month ahead of a similar compound from Novartis. “It’s a super exciting molecule and a ...

The quality of life of patients with sickle cell anemia is severely compromised similar to or even worse than patients with other chronic diseases such as arthritis. Patients who responded to ...